Bronchitis: FDA reporting patterns
73,425 FDA FAERS reports mention Bronchitis. 47,763 reports have a serious outcome flag.
Medicines named as suspect
- Etanercept: 6,772 reports
- Adalimumab: 6,102 reports
- Methotrexate: 2,443 reports
- Lenalidomide: 2,424 reports
- Fluticasone: 2,214 reports
- Tofacitinib: 2,105 reports
- Human Immunoglobulin G: 2,096 reports
- Omalizumab: 2,016 reports
- Albuterol: 1,971 reports
- Rituximab: 1,773 reports
- Infliximab: 1,746 reports
- Dupilumab: 1,713 reports
FAERS reports describe events reported after a medicine was taken. They do not prove that the medicine caused an event, measure how often a side effect occurs, or estimate personal risk.
Source: FDA FAERS via openFDA. FAERS data through 2026-06-30. Sources, methods, and limitations.